Executive Profile*

John P. Richard Ph.D., MBA

Senior Business Advisor,Agennix AG
AgeTotal Calculated CompensationThis person is connected to 94 board members in 8 different organizations across 13 different industries.

See Board Relationships
59--

Background*

Dr. John P. Richard, Ph.D., MBA, is Co-Founder of Mereo BioPharma Ltd. and serves as its Head of Corporate Development. Dr. Richard has been a Senior Business Advisor of Agennix AG since 1999. He is an Operating Partner and Non-Executive Director of Phase4 Partners Limited. He has been a Senior Business Advisor of Albireo AB since 2009. He serves as Senior Business Advisor at GPC Biotech AG. He serves as the Chief Executive Officer and Director of AxoTect, Inc. He ...

Read Full Background

Corporate Headquarters*

Im Neuenheimer Feld 515
Heidelberg, Baden-Württemberg 69120

Germany

Phone: --
Fax: --

Board Members Memberships*

Director
Director
Operating Partner and Non-Executive Director
Director
Director
Director
2013-Present
Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2015-Present
Director, Chairman of Governance & Nominating Committee and Member of Audit Committee

Education*

BS
Stanford University
MBA
Harvard Business School
PhD
Heriot-Watt University
BS
Heriot-Watt University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter M. Hecht Ph.D. Co-Founder, Chief Executive Officer and Director
Ironwood Pharmaceuticals, Inc.
$100.0K
Peter S. Greenleaf Chairman and Chief Executive Officer
Sucampo Pharmaceuticals, Inc.
$565.3K
Eduardo Javier Sanchiz Yrazu Chairman of Management Board, Chief Executive Officer and Executive Director
Almirall, S.A.
€1.2M
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.